Home » Topics » BioWorld

BioWorld
RSS

BIO-IMAGING TO ASSIST ADRIA TRIALS

Aug. 17, 1992

TARGET TO DISTRIBUTE BALT NEURO PRODUCTS

Aug. 14, 1992

MODERN THERAPIES FROM ANCIENT SOURCES

Aug. 14, 1992

BIOTECH INDEXES STUMBLE

Aug. 14, 1992

CELLCOR HOPES CLINICALS WILL COMBAT BAD PRESS

Aug. 14, 1992

DRUG DEVELOPMENT AND BIODIVERSITY

Aug. 14, 1992

CYTOGEN BEGINS TRIALS OF CANCER TREATMENT

Aug. 13, 1992

EMISPHERE BEGINS ORAL DELIVERY SYSTEM TRIALS

Aug. 13, 1992

CEPHALON RAISES $45M FOR ALS TREATMENT

Aug. 13, 1992

STEM CELL SYSTEM ENTERS CLINIC

Aug. 13, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...